Notable 52-Week Highs and Lows 9/19: (SRPT) (AMAT) (CLCD) Higher; (TNXP) (SRCL) Lower

September 19, 2016 2:53 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

52-Week High:
  • Sarepta Therapeutics' (Nasdaq: SRPT) $56.18. The U.S. Food and Drug Administration today approved Sarepta Therapeutics' Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13 percent of the population with DMD.

  • Applied Materials, Inc. (Nasdaq: AMAT) $30.78. Applied Materials and the Institute of Microelectronics (IME) announced a five-year extension of their research collaboration at the Centre of Excellence in Advanced Packaging in Singapore. The organizations will expand the scope of their R&D collaboration to focus on advancing Fan-Out Wafer-Level Packaging (FOWLP), a key technology inflection expected to help make chips and end-user devices smaller, faster and more power efficient.

  • CoLucid Pharmaceuticals, Inc.(Nasdaq: CLCD) $31.67. CoLucid Pharmaceuticals provided an interim update on its Phase 3 long-term, open-label trial evaluating lasmiditan, the GLADIATOR study. Migraine patients who have completed CoLucid’s first Phase 3 pivotal trial, SAMURAI, as well as CoLucid’s second Phase 3 pivotal trial, SPARTAN, are eligible to enroll in GLADIATOR. GLADIATOR is expected to enroll up to a total of 2,580 patients, who will be randomized to receive 100 mg or 200 mg of lasmiditan, and treat up to eight migraine attacks per month for one year.
52-Week Low:
  • Tonix Pharmaceuticals (Nasdaq: TNXP) $0.70. Tonix Pharmaceuticals filed a new investor presentation on its website. The presentation can be accessed here.

  • Stericycle (Nasdaq: SRCL) $77.00. Stericycle shares seeing additional pressure below the $80 level. The stock dropped as much as 5.2 percent today.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Add Your Comment